Micardis and Flovent drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Micardis (telmisartan) and Flovent (fluticasone propionate). Common drug interactions include oedema peripheral among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Micardis and Flovent. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Flovent?
Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.
90 people who take Micardis and Flovent together, and have interactions are studied.

What are the common drug interactions of Micardis and Flovent, by gender? *:
female:
- Oedema peripheral (superficial swelling)
- Fall
- Gait disturbance
- Insomnia (sleeplessness)
- Rash
- Sinusitis (inflammation of sinus)
- Nausea (feeling of having an urge to vomit)
- Neuropathy peripheral (surface nerve damage)
- Pain in extremity
- Wheezing (a high-pitched whistling sound made while you breath)
male:
- Diarrhoea
- Depression
- Atelectasis (partial or complete collapse of the lung)
- Back pain
- Blood urea nitrogen/creatinine ratio increased
- Bronchopleural fistula
- Bunion (a painful swelling on the first joint of the big toe)
- Cancer pain
- Cardiomegaly (increased size of heart than normal)
- Cerebrovascular disorder (disease of brain)
What are the common drug interactions of Micardis and Flovent, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
40-49:
- Myalgia (muscle pain)
- Vomiting
- Acute respiratory failure
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Arthralgia (joint pain)
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Back pain
- Blood magnesium decreased
- Blood potassium decreased
50-59:
- Cyst (a closed sac)
- Depression
- Diarrhoea
- Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
- Dyspnoea exertional (breathlessness or shortness of breath)
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
- Empyema (collection of pus in a cavity in the body)
- Eye discharge
- Faecal incontinence (a lack of control over passing stool)
- Fall
60+:
- Pneumonia
- Back pain
- Cellulitis (infection under the skin)
- Chest pain
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Erythema (redness of the skin)
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Haematochezia (passage of stools containing blood)
- Haemorrhage subcutaneous (bleeding from skin)
What are the existing conditions these people have? *
- Bone Density Abnormal: 11 people, 12.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 10.00%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 8 people, 8.89%
- Pain: 8 people, 8.89%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 8.89%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 7.78%
- Osteoporosis (bones weak and more likely to break): 7 people, 7.78%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 7.78%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 6.67%
- Sleep Disorder: 5 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Micardis and Flovent?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Micardis and Flovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Flovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Micardis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flovent and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan and fluticasone propionate (the active ingredients of Micardis and Flovent, respectively), and Micardis and Flovent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Gemzar cause Multi-Organ Failure? - 6 seconds ago
- Could Belviq cause Nosebleed? - 11 seconds ago
- Humira and Rectal Abscess for Men aged 20-29 - 27 seconds ago
- Humira and Anal Abscess for Men aged 20-29 - 28 seconds ago
- Humira and Abscess - Anorectal for Men aged 20-29 - 28 seconds ago
- Humira and Anorectal Abscess for Men aged 20-29 - 28 seconds ago
- Diplopia in Fortamet, how severe and when it was recovered? - 29 seconds ago
- Abdominal Pain Aggravated and drugs of ingredients of blinatumomab - 31 seconds ago
- Could Lovenox cause Cardiac Failure Acute? - 51 seconds ago
- Buspar and Temaz drug interactions for women aged 40-49 - a minute ago